Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016175084> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2016175084 endingPage "109" @default.
- W2016175084 startingPage "99" @default.
- W2016175084 abstract "α- and β-glucosidases are postulated to be a very attractive therapeutic target since they catalyze the cleavage of glycosidic bonds releasing glucose from the non-reducing end of an oligo- or polysaccharide chain involved in glycoprotein biosynthesis. Glucosidase inhibitors are currently of interest owing to their promising therapeutic potential in the treatment of disorders such as diabetes, AIDS, metastatic cancer and lysosomal storage diseases. α-Glucosidases can be divided into two groups, family I and family II, and the appropriate choice of the homologue enzyme to structure-based drug design purposes could prove to be successful in the development of new pharmaceuticals. In this work, we have found the highest identity of the human enzyme with the rat intestinal sucrase, when compared to other homologue proteins commonly used in biological assays, such as Saccharomyces cerevisiae α-glucosidase. Consequently, we have built and validated a 3D model for this rat enzyme, and additionally performed docking simulations of well-known glucosidase inhibitors as well as pharmacophore modeling and molecular interaction fields studies in order to establish the most relevant structural features of inhibitors and enzyme for inhibitory activity. Using this mixed methodology we have proposed how the reported inhibitors may interact at molecular level as well as discussed the role of key α-glucosidase residues in the active site, in order to design novel proposals of inhibitors. Keywords: α-Glucosidase, glucosidase inhibitor, structure-based drug design, ligand-based drug design" @default.
- W2016175084 created "2016-06-24" @default.
- W2016175084 creator A5026083298 @default.
- W2016175084 creator A5044197293 @default.
- W2016175084 creator A5067648160 @default.
- W2016175084 creator A5081662384 @default.
- W2016175084 date "2009-06-01" @default.
- W2016175084 modified "2023-09-25" @default.
- W2016175084 title "Structure and Ligand-Based Drug Design to Propose Novel α-Glucosidase Inhibitors" @default.
- W2016175084 doi "https://doi.org/10.2174/157340709788451984" @default.
- W2016175084 hasPublicationYear "2009" @default.
- W2016175084 type Work @default.
- W2016175084 sameAs 2016175084 @default.
- W2016175084 citedByCount "2" @default.
- W2016175084 countsByYear W20161750842016 @default.
- W2016175084 countsByYear W20161750842018 @default.
- W2016175084 crossrefType "journal-article" @default.
- W2016175084 hasAuthorship W2016175084A5026083298 @default.
- W2016175084 hasAuthorship W2016175084A5044197293 @default.
- W2016175084 hasAuthorship W2016175084A5067648160 @default.
- W2016175084 hasAuthorship W2016175084A5081662384 @default.
- W2016175084 hasConcept C159110408 @default.
- W2016175084 hasConcept C178910836 @default.
- W2016175084 hasConcept C181199279 @default.
- W2016175084 hasConcept C185592680 @default.
- W2016175084 hasConcept C2780035454 @default.
- W2016175084 hasConcept C41183919 @default.
- W2016175084 hasConcept C41685203 @default.
- W2016175084 hasConcept C55493867 @default.
- W2016175084 hasConcept C56173144 @default.
- W2016175084 hasConcept C70721500 @default.
- W2016175084 hasConcept C71924100 @default.
- W2016175084 hasConcept C86803240 @default.
- W2016175084 hasConcept C98274493 @default.
- W2016175084 hasConceptScore W2016175084C159110408 @default.
- W2016175084 hasConceptScore W2016175084C178910836 @default.
- W2016175084 hasConceptScore W2016175084C181199279 @default.
- W2016175084 hasConceptScore W2016175084C185592680 @default.
- W2016175084 hasConceptScore W2016175084C2780035454 @default.
- W2016175084 hasConceptScore W2016175084C41183919 @default.
- W2016175084 hasConceptScore W2016175084C41685203 @default.
- W2016175084 hasConceptScore W2016175084C55493867 @default.
- W2016175084 hasConceptScore W2016175084C56173144 @default.
- W2016175084 hasConceptScore W2016175084C70721500 @default.
- W2016175084 hasConceptScore W2016175084C71924100 @default.
- W2016175084 hasConceptScore W2016175084C86803240 @default.
- W2016175084 hasConceptScore W2016175084C98274493 @default.
- W2016175084 hasIssue "2" @default.
- W2016175084 hasLocation W20161750841 @default.
- W2016175084 hasOpenAccess W2016175084 @default.
- W2016175084 hasPrimaryLocation W20161750841 @default.
- W2016175084 hasRelatedWork W2053399516 @default.
- W2016175084 hasRelatedWork W2058600606 @default.
- W2016175084 hasRelatedWork W2058615636 @default.
- W2016175084 hasRelatedWork W2087008292 @default.
- W2016175084 hasRelatedWork W2209623591 @default.
- W2016175084 hasRelatedWork W2592608587 @default.
- W2016175084 hasRelatedWork W2620348215 @default.
- W2016175084 hasRelatedWork W2886759424 @default.
- W2016175084 hasRelatedWork W2950078978 @default.
- W2016175084 hasRelatedWork W4210753812 @default.
- W2016175084 hasVolume "5" @default.
- W2016175084 isParatext "false" @default.
- W2016175084 isRetracted "false" @default.
- W2016175084 magId "2016175084" @default.
- W2016175084 workType "article" @default.